Basic and clinical assessment of initial distribution volume of glucose in hemodynamically stable pediatric intensive

Hironori Ishihara1, Eiji Hashiba2, Hirobumi Okawa2

  • 1Department of Anesthesiology, Kuroishi-Kousei Hospital, 9-1 Tateishi, Kuroishi-shi, Aomori 036-0351 Japan.

Insights

Initial distribution volume of glucose (IDVG) can indicate fluid status in pediatric intensive care patients. Two-point IDVG measurements are more accurate than one-point for assessing extracellular fluid volume in children.

Area of Science:

  • Pediatric intensive care
  • Pharmacokinetics
  • Extracellular fluid volume assessment

Background:

  • Initial distribution volume of glucose (IDVG) is a proposed indicator of central extracellular fluid volume in adults.
  • Limited data exists on IDVG in pediatric populations.
  • This study investigated IDVG in critically ill children.

Purpose of the Study:

  • To examine pharmacokinetic data of IDVG in children.
  • To compare IDVG with other clinical variables.
  • To evaluate IDVG as a marker for fluid volume status in pediatric patients.

Main Methods:

  • Analyzed 128 daily data sets from 60 pediatric intensive care patients (body weight ≥8.0 kg).
  • Administered glucose (0.1 g/kg) and determined IDVG using a one-compartment model.
  • Calculated approximated IDVG (1-point and 2-point) and evaluated correlations with cardiac output and circulating blood volume.

Main Results:

  • Mean indexed IDVG (IDVGI) was 144 ± 22 mL/kg in 55 children.
  • Two-point IDVG showed better bias and precision compared to 1-point IDVG.
  • Postoperative IDVGI increased in the first two days after cardiovascular surgery.
  • IDVGI correlated significantly with indexed cardiac output and circulating blood volume.

Conclusions:

  • IDVG shows potential as a fluid volume status marker in children.
  • Body movement during measurement is a significant limitation for IDVG determination.
  • Two-point IDVG is a more reliable method for approximating IDVG in pediatric patients.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
896
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
1.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
495